Status:
RECRUITING
Thrombus Composition in Ischemic Stroke: Analysis of the Correlation With Plasma Biomarkers, Efficacy of Treatment, Etiology and Prognosis
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Stroke, Acute
Biological Specimen Banks
Eligibility:
All Genders
18+ years
Brief Summary
The recent validation of thrombectomy in addition to thrombolysis with intravenous administration of alteplase suggests a major revolution in the management of acute strokes. This treatment option als...
Eligibility Criteria
Inclusion
- Patient aged 18 years and older; having a cerebral infarction following arterial occlusion; treated by thrombectomy; patient in whom a thrombus could be collected.
Exclusion
- Patient benefiting from a legal protection measure; pregnant or breastfeeding woman
Key Trial Info
Start Date :
July 13 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT03268668
Start Date
July 13 2017
End Date
October 1 2027
Last Update
June 25 2025
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Bordeaux
Bordeaux, France, 33000
2
CHU Caen
Caen, France
3
Chu Limoges
Limoges, France, 87000
4
CHRU de Nancy
Nancy, France, 54000